Group 1: All patients treated at the Department of Neurology at Heidelberg University Hospital with a tumor of the central nervous system (CNS), for whom data are available between January 1, 2000, an

2 trials

Sponsors

Neurologische Klinik, Universitätsklinikum Heidelberg

Conditions

C71ICD-10 codes C71.- and C72.- (primary CNS tumors), as well as C79.3 and C79.4 (secondary CNS tumors) C71 C72 C79.3 C79.4

Unknown Phase

Impact of Anti-Glutamatergic Medications on Survival in Glioma Patients: A Retrospective Cohort Study

Active, not recruitingDRKS00037941

Neurologische Klinik, Universitätsklinikum HeidelbergC71

Start: 2027-06-01Target: 5000Updated: 2026-08-03

Predictors of Brain Tumor-Associated Epilepsy: A Retrospective Cohort Study

Active, not recruitingDRKS00037942

Neurologische Klinik, Universitätsklinikum HeidelbergICD-10 codes C71.- and C72.- (primary CNS tumors), as well as C79.3 and C79.4 (secondary CNS tumors) C71 C72 C79.3 C79.4

Start: 2026-12-01Target: 10000Updated: 2026-08-03